Kim Rijkers

Kim Rijkers

Auto-generated profile, based on publicly available information

Kim Rijkers

Maastricht University, P. Debyelaan 25, 6229 HX Maastricht, Netherlands, Maastricht, LI, 6200 MD, NETHERLANDS

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Experimental Neurology
Verified
Journal Article
Closed access
KRK. Rijkers
K. Rijkers
HMH.J. Majoie
H.J. Majoie
GHG. Hoogland
G. Hoogland
GKG. Kenis
G. Kenis
MBM. De Baets
M. De Baets
JVJ.S. Vles
J.S. Vles

1 July 2007 in Journal of Neurosurgery
Verified
Journal Article
Closed access
KRKim Rijkers
Kim Rijkers
YTYasin Temel
Yasin Temel
VVVeerle Visser-Vandewalle
Veerle Visser-Vandewalle
LVLinda Vanormelingen
Linda Vanormelingen
MVMarjan Vandersteen
Marjan Vandersteen
EBEmile A. M. Beuls
Emile A. M. Beuls
High-frequency stimulation of the subthalamic nucleus (STN) is a widely performed method to treat advanced Parkinson disease. Due to the limitations of current imaging techniques, the 3D microanatomy of the STN and its surrounding structures in the mesencephalon are not well known. Using images they obtained using a 9.4-tesla magnetic resonance (MR) imaging unit, the authors developed a 3D reconstruction of the STN and its immediate surroundings. During the postmortem investigation of a human brain, a sample of tissue in the area around the STN was isolated. This brain tissue was scanned in the three orthogonal planes at 1-mm slice thickness. The images generated were compared with photographs of conventionally stained brain tissue slices in different neuroanatomical books, and a 3D reconstruction was made. High-field MR imaging is an appropriate method for visualizing the microanatomy of the STN and its surroundings. The images allow an optimal analysis of the microenvironment of the STN in the three orthogonal planes and can be used for 3D reconstructions of this area with possible clinical applications in the future.

13 December 2023 in Brain and Spine
Verified
Journal Article
Open access
JSJouke van Schooten
Jouke van Schooten
JSJacco Smeets
Jacco Smeets
SKSander Mj. van Kuijk
Sander Mj. van Kuijk
SKSylvia Klinkenberg
Sylvia Klinkenberg
OSOlaf E. M. G. Schijns
Olaf E. M. G. Schijns
KRKim Rijkers
Kim Rijkers
Vagus nerve stimulation (VNS) is the most frequently used neuromodulation treatment for Drug-Resistant Epilepsy (DRE) patients. Complications of VNS surgery include surgical site infection and unilateral vocal cord paresis. Complication rates vary across studies. What is the safety profile of VNS related surgeries? Retrospective cohort study using patient files of DRE-patients who had undergone primary implantation of a VNS-system, replacement of the VNS pulse generator, replacement of the lead, replacement of both pulse generator and lead, or VNS removal surgery in the Maastricht UMC+. Multiple Imputation was used for missing data. Univariable and multivariable logistic regression analysis were performed to analyze possible risk factors, in case of a small sample size, an independent-samples t-test and Fisher's exact test or Pearson's X2-test were used. The complication rate was calculated as percentage. This study included a total of 606 VNS surgical procedures, leading to 67 complications of which 3 permanent complications. Complication rate after primary implantation was 13.4%; 2,5% for pulse generator replacement; 21.4% for lead revision and 27.3% for complete VNS removal. No statistically significant results were found when analyzing the results of adults and children <18 years separately. Complication rates of VNS-related surgeries in our own institutional series are low and comparable to previously reported series. VNS surgery is a relatively safe procedure. The complication rate differs per type of surgery and mean surgery duration was longer for patients with complications after lead revision surgery compared to patients without complications.

1 March 2010 in Brain Research
Verified
Journal Article
Closed access
KRKim Rijkers
Kim Rijkers
MAMarlien Aalbers
Marlien Aalbers
GHGovert Hoogland
Govert Hoogland
LWLarissa van Winden
Larissa van Winden
JVJohannes Vles
Johannes Vles
MMMarian Majoie
Marian Majoie

25 February 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DPDemi S. Post
Demi S. Post
AVArian van der Veer
Arian van der Veer
OSOlaf E. M. G. Schijns
Olaf E. M. G. Schijns
SKSylvia Klinkenberg
Sylvia Klinkenberg
KRKim Rijkers
Kim Rijkers
YHYvonne M. C. Henskens
Yvonne M. C. Henskens
Introduction: Valproic acid (VPA) is a frequently prescribed anti-epileptic drug. Since its introduction side effects on hemostasis are reported. However, studies show conflicting results, and the clinical relevance is questioned. We aimed to determine the coagulopathies induced by VPA in patients who undergo high-risk surgery. The study results warrant attention to this issue, which might contribute to reducing bleeding complications in future patients. Methods: Between January 2012 and August 2020, 73 consecutive patients using VPA were retrospectively included. Extensive laboratory hemostatic assessment (including platelet function tests) was performed before elective high-risk surgery. Patient characteristics, details of VPA treatment, and laboratory results were extracted from medical records. Results: 46.6% of the patients using VPA (n = 73) showed coagulopathy. Mainly, platelet function disorder was found (36.4%). Thrombocytopenia was seen in 9.6% of the patients. Data suggested that the incidence of coagulopathies was almost twice as high in children as compared to adults and hypofibrinogenemia was only demonstrated in children. No association was found between the incidence of coagulopathies and VPA dosage (mg/kg/day). Conclusion: A considerable number of patients using VPA were diagnosed with coagulopathy, especially platelet function disorder. Further prospective studies are needed to confirm the need for comprehensive laboratory testing before elective high-risk surgery in these patients.

8 August 2024 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Open access
RSRutger Slegers
Rutger Slegers
LWLouis Wagner
Louis Wagner
SKSander van Kuijk
Sander van Kuijk
DHDanny Hilkman
Danny Hilkman
PHPaul Hofman
Paul Hofman
OSOlaf E. M. G. Schijns
Olaf E. M. G. Schijns
Periventricular nodular heterotopias (PVNH) are developmental abnormalities with neurons abnormally clustered around the cerebral ventricles. Patients frequently present with focal drug-resistant epilepsy (DRE). However, the relationship between PVNH and the seizure onset zone (SOZ) is complex. Stereo-electroencephalography (SEEG) is an invasive diagnostic procedure for patients with DRE. In selected patients, the SEEG may be converted into a therapeutic procedure, lesioning the probable (SOZ) with pulsed radiofrequency thermocoagulation (RFTC). The aim of our study was to evaluate the efficacy and safety of SEEG-RFTC in a series of DRE patients with PVNH. Twenty-four patients with focal DRE related to PVNH and treated with SEEG-guided-RFTC restricted to nodules were prospectively collected between 2016 and 2023 and retrospectively analyzed after a follow-up of at least 12 months. Seventeen patients (71 %) responded (ILAE class 1-4) after SEEG-guided RFTC of whom eleven (46 %) became seizure-free (class 1) at last follow up, nine (45 %) despite residual PVNH tissue on MRI. SEEG seizure onset was restricted to PVNH in eleven patients (class 1 in 45 %) and simultaneously in PVNH and other cortical areas in thirteen patients (class 1 in 46 %). Out of 31 SEEG-RFTC procedures in twenty-four patients, adverse events, related to RFTC, were recorded in eight (26 %), of which two patients (8 %) had predicted permanent visual complaints whilst the other five had transient complaints. This study demonstrates that a considerable percentage of patients, even with bilateral, multiple PVNH and involvement of adjacent cortical regions can be rendered seizure-free with SEEG-guided-RFTC restricted to the nodules. Furthermore, this study delivers evidence that the complete destruction of the entire nodule is not necessary to render a patient seizure free. This justifies the use of SEEG in patients with single, multiple or bilateral PVNHs to provide insight into the epileptogenic organization in and around these lesions.